- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04715035
Efficacy of Eccentric Exercises in Individuals With Frozen Shoulder
Efficacy of Eccentric Exercises in Individuals With Frozen Shoulder: A Randomized Controlled Clinical Trial
Frozen shoulder is a musculoskeletal condition with a strong negative impact on activities of daily living, producing pain, disability, anxiety, and sleep disorders. It has a worldwide prevalence of 5.3%, increasing from 10 to 38% in patients with diabetes and thyroid conditions. This clinical entity manifests itself mainly in women between 40 and 65 years of age. Its resolution time is long and can reach 42 months with symptoms that persist throughout life.
In the clinical evaluation, patients with Frozen Shoulder are manifested mainly by presenting mobility deficits. Previous studies described different structural alterations that may justify this clinical condition and its consequences, such as, for example, fibrosis of the coracohumeral ligament, alterations of the rotator interval, and of the axillary recess.
Although passive structures are believed to be primarily involved in this condition, A series of five cases in which patients with frozen shoulder presented a significant increase in mobility after a general anesthetic block. The data obtained from this study and the different complications presented by patients with CH suggest that it is necessary to further understand the role of the rotator cuff in this clinical condition.
Eccentric exercises consist of contracting the muscle to control or decelerate a load while the muscle or tendon is lengthening or remaining stretched. This intervention has been proposed for the treatment of tendinopathies in different body regions.
Study Overview
Status
Intervention / Treatment
Detailed Description
A randomized controlled clinical trial with two parallel groups will be carried out. Evaluators will be blinded to the treatment group and therapists will be unique to each group. This study will follow the CONSORT guidelines.
Randomization by blocks between groups will be carried out through the website www.randomization.com and the sequence will be stored in sealed and opaque envelopes to maintain allocation confidentiality. This process will be carried out by an independent researcher, who will not be involved in the assessment and treatment. The allocation of subjects will be revealed to the researcher responsible for the treatment by opening the envelope before the start of the intervention. The researcher responsible for the evaluation will be blinded to the treatment group. The individuals will be blinded in relation to the study hypothesis and will not have contact with the participants of the same or the other group.
Initially, all participants will undergo screening to assess the inclusion and non-inclusion criteria of the study. All individuals who meet the eligibility criteria will undergo an anamnesis to collect personal, sociodemographic, pain history, and primary and secondary outcomes measurements.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Buenos Aires City
-
Buenos Aires, Buenos Aires City, Argentina, 1405
- Durand Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- History of diffuse-onset shoulder pain of at least one month
- Gradual loss of passive external rotation of at least 50% compared to the contralateral side
Exclusion Criteria:
- History of shoulder fracture/ surgery
- Shoulder pain reproduced by passive movement of the cervical spine
- History of rheumatoid arthritis
- Shoulder immobilization for more than 5 days
- Bilateral frozen shoulder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conventional treatment
Physical therapy: education, mobilizations, stretch, active exercises, home excercises.
|
mobilization, stretch, education, eccentric exercises
|
|
Experimental: Conventional treatment + eccentric exercises
Physical therapy: education, mobilizations, stretch, active exercises, home exercises, eccentric exercises.
|
mobilization, stretch, education, eccentric exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder Function
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
American Shoulder and Elbow Surgeons scale (ASES).
This scale has a score between 0 to 100.
When the score is more close to 0 Worst is the function of the shoulder and when is approximate 100, it is better.
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of Movement
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
An inclinometer will assess flexion, external rotation, and internal rotation range of movement.
The higher the value, the better.
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Perceived Pain
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
The perceived pain is going to be assessed by a Visual Analogue Scale from 0 to 10, where the score close to 0 is worst, and approximate to 10 is better.
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Pennation Angle
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
It is going to be assessed by an ultrasound device
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Fear avoidance
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
Fear Avoidance Beliefs Questionnaire This scale has a score between 0 to 96.
When the score is more close to 96 worst is the fear avoidance and when is approximate to 0, it is better.
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Perceived Quality of life
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
European Quality of Life Scale of five domains (EQ5D-3L).
This scale has five items with a score between 1 to 3. When the score is more close to 3 worst is the quality of life and when is approximate to 1, it is better in each item.
Also has a visual analogue scale of 100 points to assess the health condition, when the score is more close to 0 worst is the quality of life and when is approximate to 100 it is better.
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Muscle Thickness
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
It is going to be assessed by an ultrasound device
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
|
Pain Catastrophizing
Time Frame: From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
Pain Catastrophizing Scale (PCS)
|
From enrollment to the end of treatment at 12 weeks. In the follow-up at 3 months and 9 months from the end of treatment.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Paula Camargo, PhD, University of São Carlos
Publications and helpful links
General Publications
- 1. Ryan V, Brown H, Minns Lowe CJ, Lewis JS. The pathophysiology associated with primary (idiopathic) frozen shoulder: A systematic review. BMC Musculoskelet Disord. 2016 Aug 15;17(1):340. 2. Kelley MJ, McClure PW, Leggin BG. Frozen shoulder: evidence and a proposed model guiding rehabilitation. J Orthop Sports Phys Ther. 2009 Feb;39(2):135-48. 3. Lewis J. Frozen shoulder contracture syndrome - Aetiology, diagnosis and management. Man Ther. 2015 Feb;20(1):2-9. 4. Chan HBY, Pua PY, How CH. Physical therapy in the management of frozen shoulder. Singapore Med J. 2017 Dec;58(12):685-689. 5. Kelley MJ, Shaffer MA, Kuhn JE, Michener LA, Seitz AL, Uhl TL, Godges JJ, McClure PW. Shoulder pain and mobility deficits: adhesive capsulitis. J Orthop Sports Phys Ther. 2013 May;43(5):A1-31. 6. Hollmann L, Halaki M, Kamper SJ, Haber M, Ginn KA. Does muscle guarding play a role in range of motion loss in patients with frozen shoulder? Musculoskelet Sci Pract. 2018 Oct;37:64-68.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Policastro.ECA.HombroCongelado
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frozen Shoulder
-
Riphah International UniversityRecruitingShoulder FrozenPakistan
-
Massachusetts General HospitalRecruitingAdhesive Capsulitis | Frozen Shoulder | Shoulder FrozenUnited States
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Inonu UniversityNot yet recruiting
-
China Medical University HospitalNot yet recruitingFrozen Shoulder | Adhesive Capsulitis of the ShoulderTaiwan
-
HAN University of Applied SciencesNetherlands Organisation for Scientific ResearchNot yet recruitingShoulder Instability | Frozen Shoulder | Rotator Cuff SyndromeNetherlands
-
University of California, San FranciscoNot yet recruitingFrozen Shoulder | Adhesive Capsulitis of the ShoulderUnited States
-
University of Sao PauloCompletedShoulder Pain | Frozen Shoulder,Brazil
-
University of ValenciaCompletedAdhesive Capsulitis of Shoulder | Frozen ShoulderSpain
-
University of NottinghamNot yet recruiting
Clinical Trials on Physical therapy interventions
-
Horus UniversityCompletedChild Development | Physical Therapy | Developmental DelayEgypt
-
Riphah International UniversityRecruitingKnee Osteoarthritis (Knee OA)Pakistan
-
Reynolds Army Community HospitalTemple University; Brooke Army Medical CenterUnknownPhysical Therapy Direct Access | Physical Therapy Primary CareUnited States
-
University of HailCompletedCerebral PalsySaudi Arabia
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
VA Office of Research and DevelopmentCompletedPhysical Deconditioning | MultimorbidityUnited States
-
VA Office of Research and DevelopmentRecruitingPhysical Deconditioning | MultimorbidityUnited States
-
University of PecsCompletedFall | Elderly Population | Exercise InterventionHungary
-
University of Maryland, BaltimoreNorthwestern University; VA Maryland Health Care SystemCompletedAccidental FallsUnited States
-
Cumhuriyet UniversityCompletedCIPN - Chemotherapy-Induced Peripheral Neuropathy | Oxaliplatin | Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsTurkey (Türkiye)